Timing of intrathecal chemotherapy and blinatumomab impacts neurotoxicity in acute lymphoblastic leukemia

被引：3
|
作者：
Lee, Benjamin J. J. [1 ,4 ]
Griffin, Shawn P. P. [1 ,2 ]
Doh, Jean [1 ]
Kongtim, Piyanuch [3 ]
Chan, Alexandre [1 ,2 ]
O'Brien, Susan [3 ]
Jeyakumar, Deepa [3 ]
Ciurea, Stefan O. O. [3 ]
机构：
[1] Univ Calif Irvine Hlth, Chao Family Comprehens Canc Ctr, Dept Pharm, Orange, CA 92868 USA
[2] Univ Calif Irvine, Sch Pharm & Pharmaceut Sci, Dept Clin Pharm Practice, Irvine, CA USA
[3] Univ Calif Irvine Hlth, Chao Family Comprehens Canc Ctr, Dept Med, Div Hematol Oncol, Orange, CA 92868 USA
[4] Univ CaliforniaIrvine Hlth, Dept Pharm, 101 City Dr South,Bldg 23,Rm 275, Orange, CA 92868 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 05期
关键词：
D O I：
10.1002/ajh.26880
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E113 / E115
页数：3
相关论文
共 50 条
  • [31] Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemia
    Wei, Andrew H.
    Ribera, Josep-Maria
    Larson, Richard A.
    Ritchie, David
    Ghobadi, Armin
    Chen, Yuqi
    Anderson, Abraham
    Dos Santos, Cedric E.
    Franklin, Janet
    Kantarjian, Hagop
    LEUKEMIA, 2021, 35 (08) : 2220 - 2231
  • [32] Blinatumomab in adult acute lymphoblastic leukemia right now
    Cutini, Ilaria
    Bosi, Alberto
    DRUGS AND CELL THERAPIES IN HEMATOLOGY, 2015, 3 (02): : 82 - 91
  • [33] Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemia
    Andrew H. Wei
    Josep-Maria Ribera
    Richard A. Larson
    David Ritchie
    Armin Ghobadi
    Yuqi Chen
    Abraham Anderson
    Cedric E. Dos Santos
    Janet Franklin
    Hagop Kantarjian
    Leukemia, 2021, 35 : 2220 - 2231
  • [34] BLINATUMOMAB AS A BRIDGE THERAPY TO TRANSPLANTATION IN ACUTE LYMPHOBLASTIC LEUKEMIA
    Marchante Cepillo, I.
    Rodriguez Servan, I.
    Fernandez Valle, M. C.
    HAEMATOLOGICA, 2018, 103 : 205 - 206
  • [35] TIMING OF MAINTENANCE CHEMOTHERAPY FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - REPLY
    RIVARD, GE
    INFANTERIVARD, C
    HOYEUX, C
    CHAMPAGNE, J
    LANCET, 1986, 1 (8490): : 1161 - 1161
  • [36] Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia
    Stein, Anthony S.
    Larson, Richard A.
    Schuh, Andre C.
    Stevenson, William
    Lech-Maranda, Ewa
    Tran, Qui
    Zimmerman, Zachary
    Kormany, William
    Topp, Max S.
    BLOOD ADVANCES, 2018, 2 (13) : 1522 - 1531
  • [37] Analysis of the Timing of Initial Intrathecal Methotrexate Therapy for Acute Lymphoblastic Leukemia at a Single Institution
    Yanagi, Masato
    Sugawa, Masahiro
    Noguchi, Shun
    Kawakami, Ryota
    Itabashi, Toshikazu
    Isobe, Kiyotaka
    Mori, Makiko
    Arakawa, Yuki
    Ko, Katsuyoshi
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S16 - S17
  • [38] Neurotoxicity with blinatumomab in combination with intrathecal methotrexate therapy
    On, Sandy
    Kuo, Eric
    Lau, Kimberly M.
    LEUKEMIA & LYMPHOMA, 2023, 64 (01) : 246 - 249
  • [39] Severe Neurotoxicity Following Intrathecal Methotrexate With Nitrous Oxide Sedation in a Child With Acute Lymphoblastic Leukemia
    Loebel, U.
    Trah, J.
    Escherich, G.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (03) : 539 - 541
  • [40] ACUTE FATAL MYELOENCEPHALOPATHY AFTER COMBINED INTRATHECAL CHEMOTHERAPY IN A CHILD WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    VONDERWEID, NX
    DECROUSAZ, H
    BECK, D
    DEONNA, T
    MIKLOSSY, J
    JANZER, RC
    MEDICAL AND PEDIATRIC ONCOLOGY, 1991, 19 (03): : 192 - 198
12345